Tenet Healthcare (NYSE:THC) EVP Sells $2,653,144.20 in Stock

Tenet Healthcare Corporation (NYSE:THC) EVP Paola Arbour sold 10,878 shares of Tenet Healthcare stock in a transaction dated Monday, July 27th. The stock was sold at an average price of $243.90, for a total value of $2,653,144.20. Following the completion of the transaction, the executive vice president directly owned 18,413 shares of the company’s stock, valued at approximately $4,490,930.70. This represents a 37.14% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Tenet Healthcare Stock Performance

Shares of THC stock opened at $252.80 on Friday. The company has a market capitalization of $21.78 billion, a price-to-earnings ratio of 9.75, a price-to-earnings-growth ratio of 0.98 and a beta of 1.27. The company has a debt-to-equity ratio of 2.00, a quick ratio of 1.35 and a current ratio of 1.41. Tenet Healthcare Corporation has a one year low of $156.71 and a one year high of $262.68. The company’s 50-day moving average is $190.49 and its 200 day moving average is $198.96.

Tenet Healthcare (NYSE:THC) last issued its earnings results on Thursday, July 23rd. The company reported $6.12 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.26 by $1.86. Tenet Healthcare had a net margin of 10.27% and a return on equity of 26.76%. The business had revenue of $6.04 billion during the quarter, compared to analysts’ expectations of $5.43 billion. During the same period in the previous year, the company earned $4.02 earnings per share. The business’s revenue for the quarter was up 6.8% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. Sell-side analysts expect that Tenet Healthcare Corporation will post 21.09 EPS for the current fiscal year.

Institutional Trading of Tenet Healthcare

Hedge funds have recently bought and sold shares of the company. Swedbank AB grew its stake in shares of Tenet Healthcare by 14.7% during the 4th quarter. Swedbank AB now owns 146,133 shares of the company’s stock valued at $29,040,000 after purchasing an additional 18,750 shares during the period. Jackson Creek Investment Advisors LLC boosted its holdings in shares of Tenet Healthcare by 235.6% in the fourth quarter. Jackson Creek Investment Advisors LLC now owns 9,032 shares of the company’s stock worth $1,795,000 after buying an additional 6,341 shares during the last quarter. Hsbc Holdings PLC grew its position in Tenet Healthcare by 3,478.7% during the fourth quarter. Hsbc Holdings PLC now owns 266,400 shares of the company’s stock valued at $53,269,000 after buying an additional 258,956 shares during the period. Louisiana State Employees Retirement System purchased a new stake in Tenet Healthcare during the first quarter valued at approximately $4,812,000. Finally, Brandywine Global Investment Management LLC boosted its stake in shares of Tenet Healthcare by 20.5% during the 4th quarter. Brandywine Global Investment Management LLC now owns 126,248 shares of the company’s stock worth $25,088,000 after acquiring an additional 21,435 shares during the last quarter. Hedge funds and other institutional investors own 95.44% of the company’s stock.

Tenet Healthcare News Summary

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Analysts raised their price targets: Truist lifted its target to $290, while Guggenheim increased its target to $283 and Robert W. Baird raised its target to $280. The revisions reflect growing confidence in Tenet’s earnings outlook and imply additional upside from recent trading levels. Truist raises Tenet Healthcare price target Baird analyst comments on Tenet Healthcare Guggenheim analyst comments on Tenet Healthcare
• Positive Sentiment: Growth and momentum remain key attractions: Zacks highlighted Tenet’s above-average financial growth, strong momentum characteristics and potential appeal to growth-focused investors. These reports may support continued retail and quantitative-investor interest in THC. Three reasons growth investors may like Tenet Healthcare Tenet Healthcare momentum analysis
• Positive Sentiment: Fundamental performance supports the bullish case: Tenet’s latest quarterly results exceeded estimates, with EPS of $6.12 versus a $4.26 consensus and revenue of $6.04 billion versus $5.43 billion expected. The company also raised its 2026 outlook, strengthening the investment case behind the recent rally.
• Neutral Sentiment: Investor attention is elevated: Zacks reported increased user interest in Tenet and noted that the stock recently reached a 52-week high. However, the coverage is largely informational and does not represent a new company announcement or change in fundamentals. Zacks analysis of investor attention on Tenet Healthcare
• Negative Sentiment: Insider selling creates a modest overhang: EVP Paola Arbour sold 10,878 shares for approximately $2.65 million, while Director Christopher Lynch sold 3,837 shares worth about $934,000. Both transactions significantly reduced their holdings, although the sales may reflect personal financial planning rather than a negative view of Tenet’s prospects.

Analysts Set New Price Targets

A number of analysts have commented on the company. KeyCorp reduced their target price on Tenet Healthcare from $250.00 to $225.00 and set an “overweight” rating for the company in a report on Friday, May 1st. Barclays increased their price objective on Tenet Healthcare from $240.00 to $271.00 and gave the company an “overweight” rating in a research report on Friday, July 24th. Morgan Stanley boosted their target price on Tenet Healthcare from $254.00 to $274.00 and gave the stock an “overweight” rating in a research report on Monday. Royal Bank Of Canada raised their price target on shares of Tenet Healthcare from $236.00 to $283.00 and gave the company an “outperform” rating in a report on Monday. Finally, Wells Fargo & Company lifted their price target on shares of Tenet Healthcare from $213.00 to $231.00 and gave the stock an “overweight” rating in a research note on Monday, July 13th. Seventeen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $268.50.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.